Christina Slavin
Family · Kilmarnock, VANPI 1639179666
Payments from drug & device makers
Across 121 payments — averaging $19.67 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novo Nordisk$341
- Amgen$275
- AbbVie$262
- Abbott$230
- Pfizer$186
- Boehringer Ingelheim$148
- plus $938 from 24 others
What the payments were for
- Food & beverage$2,380100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novo Nordisk | 19 | $341 |
| Amgen | 17 | $275 |
| AbbVie | 13 | $262 |
| Abbott | 11 | $230 |
| Pfizer | 11 | $186 |
| Boehringer Ingelheim | 2 | $148 |
| AstraZeneca | 9 | $126 |
| Lilly USA, LLC | 8 | $126 |
| Scpharmaceuticals Inc. | 2 | $81 |
| Daiichi Sankyo Inc. | 3 | $64 |
| Biohaven Pharmaceutical Holding Company Ltd. | 1 | $53 |
| GSK | 3 | $48 |
| Neurocrine Biosciences, Inc. | 2 | $46 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $37 |
| Dexcom, Inc. | 2 | $37 |
| Mylan Specialty L.p. | 2 | $35 |
| Corcept Therapeutics | 1 | $34 |
| Merck | 1 | $31 |
| Almatica Pharma LLC | 1 | $27 |
| CSL Behring | 1 | $25 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
| Exact Sciences | 1 | $23 |
| Smith+Nephew | 1 | $19 |
| Philips North America LLC | 1 | $18 |
| Novartis | 1 | $16 |
| Sumitomo Pharma America, Inc. | 1 | $15 |
| Eisai Inc. | 1 | $14 |
| Otsuka America Pharmaceutical, Inc. | 1 | $14 |
| Nestle Healthcare Nutrition Inc. | 1 | $14 |
| Amarin Pharma, Inc. | 1 | $13 |
How this compares
$2,380 in reported general payments places this provider in the 85th percentile of 4,332 family providers in Virginia.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 99 | $78,893 |
| OzempicSemaglutide | 29 | $37,840 |
| TrulicityDulaglutide | 11 | $24,249 |
| MounjaroTirzepatide | 22 | $22,579 |
| JardianceEmpagliflozin | 11 | $16,653 |
| Spiriva RespimatTiotropium Bromide | 16 | $13,864 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $9,996 |
| EntrestoSacubitril/Valsartan | 15 | $6,711 |
| Celecoxib | 29 | $3,326 |
| Atorvastatin Calcium | 242 | $2,062 |
| Brinzolamide | 16 | $2,027 |
| Bupropion XlBupropion Hcl | 49 | $1,983 |
| Levothyroxine Sodium | 171 | $1,903 |
| Omeprazole | 109 | $1,694 |
| Gabapentin | 73 | $1,571 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis, Paxlovid | $186 | $80,322113 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $126 | $46,82833 claims |
| Novo NordiskOzempic | $341 | $37,84029 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat | $148 | $30,51727 claims |
| GSKBreo Ellipta | $48 | $9,99616 claims |
| NovartisEntresto | $16 | $6,71115 claims |
| AbbVieSynthroid | $262 | $1,17113 claims |
| Almatica Pharma LLCSertraline Hcl | $27 | $63962 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 4,332 family providers in Virginia.
Other family in Kilmarnock
- Andrea CottonVirginia Beach$696K
- Susan MooreWytheville$438K
- Ellen WermterCharlottesville$251K
- Dana StallingsFranklin$225K
- Jocelyn BrackettHerndon$199K
- Hochong Smith GillesRichmond$131K
- Sean OlaughlinMidlothian$110K
- Adam MedlinHampton$67K
- Casey SharpDanville$63K
- Norman JacobowitzManassas$55K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.